BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Germ cell tumor AND ZNF331, Q9NQX6, 55422, ENSG00000130844, ZNF361, RITA, ZNF463
17 results:

  • 1. [rita selectively inhibits proliferation of
    Shi W; Liu X; Zhang G; Ye L; Zhou R; Li Y; Yu L
    Nan Fang Yi Ke Da Xue Xue Bao; 2023 May; 43(5):710-717. PubMed ID: 37313811
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Genomic Landscape of Malignant Peripheral Nerve Sheath tumor‒Like Melanoma.
    Muniz TP; Sorotsky H; Kanjanapan Y; Rose AAN; Araujo DV; Fortuna A; Ghazarian D; Kamil ZS; Pugh T; Mah M; Thiagarajah M; Torti D; Spreafico A; Hogg D
    J Invest Dermatol; 2021 Oct; 141(10):2470-2479. PubMed ID: 33831431
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Repeated gamma knife radiosurgery enables longer tumor control in cases of highly-recurrent intracranial ependymoma.
    Lin YY; Wu HM; Yang HC; Chen CJ; Lin CJ; Chen YW; Chen HH; Wong TT; Hu YS; Chung WY; Shiau CY; Guo WY; Pan DH; Lee CC
    J Neurooncol; 2020 Jun; 148(2):363-372. PubMed ID: 32405998
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Targeted therapy based on p53 reactivation reduces both glioblastoma cell growth and resistance to temozolomide.
    Forte IM; Indovina P; Iannuzzi CA; Cirillo D; Di Marzo D; Barone D; Capone F; Pentimalli F; Giordano A
    Int J Oncol; 2019 Jun; 54(6):2189-2199. PubMed ID: 31081046
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Study on Therapeutic Action and Mechanism of TMZ Combined with rita Against Glioblastoma.
    Wu Q; Cao Z; Xiao W; Zhu L; Xie Q; Li L; Zhang B; Zhao W
    Cell Physiol Biochem; 2018; 51(6):2536-2546. PubMed ID: 30562758
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. rita downregulates Hedgehog-GLI in medulloblastoma and rhabdomyosarcoma via JNK-dependent but p53-independent mechanism.
    Azatyan A; Gallo-Oller G; Diao Y; Selivanova G; Johnsen JI; Zaphiropoulos PG
    Cancer Lett; 2019 Feb; 442():341-350. PubMed ID: 30447254
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. rita displays anti-tumor activity in medulloblastomas independent of TP53 status.
    Gottlieb A; Althoff K; Grunewald L; Thor T; Odersky A; Schulte M; Deubzer HE; Heukamp L; Eggert A; Schramm A; Schulte JH; Künkele A
    Oncotarget; 2017 Apr; 8(17):27882-27891. PubMed ID: 28427187
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. [rita combined with temozolomide inhibits the proliferation of human glioblastoma U87 cells].
    He XY; Feng XL; Song XP; Zeng HC; Cao ZX; Xiao WW; Zhang B; Wu QH
    Nan Fang Yi Ke Da Xue Xue Bao; 2016 Oct; 36(10):1423-1428. PubMed ID: 27777210
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Dual targeting of wild-type and mutant p53 by small molecule rita results in the inhibition of N-Myc and key survival oncogenes and kills neuroblastoma cells in vivo and in vitro.
    Burmakin M; Shi Y; Hedström E; Kogner P; Selivanova G
    Clin Cancer Res; 2013 Sep; 19(18):5092-103. PubMed ID: 23864164
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Human neuroblastoma cells with acquired resistance to the p53 activator rita retain functional p53 and sensitivity to other p53 activating agents.
    Michaelis M; Rothweiler F; Agha B; Barth S; Voges Y; Löschmann N; von Deimling A; Breitling R; Doerr HW; Rödel F; Speidel D; Cinatl J
    Cell Death Dis; 2012 Apr; 3(4):e294. PubMed ID: 22476102
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Synergistic growth inhibition based on small-molecule p53 activation as treatment for intraocular melanoma.
    de Lange J; Ly LV; Lodder K; Verlaan-de Vries M; Teunisse AF; Jager MJ; Jochemsen AG
    Oncogene; 2012 Mar; 31(9):1105-16. PubMed ID: 21765463
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Intraoperative radiofrequency ablation (RFA) for irresectable liver malignancies.
    Tepel J; Hinz S; Klomp HJ; Kapischke M; Kremer B
    Eur J Surg Oncol; 2004 Jun; 30(5):551-5. PubMed ID: 15135485
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Laparoscopic radiofrequency ablation of hepatic tumors: prospective clinical evaluation of ablation size comparing two treatment algorithms.
    Berber E; Herceg NL; Casto KJ; Siperstein AE
    Surg Endosc; 2004 Mar; 18(3):390-6. PubMed ID: 14735342
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. [Flexible applicator systems for radiofrequency ablation (RFA) of hepatic tumors].
    Gebauer B; Gaffke G; Hünerbein M; Felix R; Stroszczynski C
    Rofo; 2003 Dec; 175(12):1720-3. PubMed ID: 14661145
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Radiofrequency ablation for the management of liver tumors.
    Bachar GN; Greif F; Mor E; Tur-Kaspa R; Belenky A
    Isr Med Assoc J; 2003 Jul; 5(7):496-500. PubMed ID: 12901246
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. [Radiofrequency ablation for metastatic lung tumor].
    Ishibashi H; Takahashi H; Ashino Y; Suzuki S; Shibuya J; Hosaka T; Niikawa H; Handa M
    Kyobu Geka; 2003 Feb; 56(2):119-23. PubMed ID: 12635321
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Laparoscopic radiofrequency ablation of primary and metastatic liver tumors. Technical considerations.
    Siperstein A; Garland A; Engle K; Rogers S; Berber E; String A; Foroutani A; Ryan T
    Surg Endosc; 2000 Apr; 14(4):400-5. PubMed ID: 10790563
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.